Leukemia inhibitory factor is a mediator of Escherichia coli lipopolysaccharide-induced acute thymic atrophy

European Journal of Immunology

Volumn 32, Issue 11, 2002, Pages 3066-3070

  Sempowski, Gregory D ^a   Rhein, Maria E ^a   Scearce, Richard M ^a   Haynes, Barton F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Costicosterone; Endotoxin shock; T lymphocyte; Thymus

Indexed keywords

CORTICOSTEROID; CORTICOTROPIN; ENZYME INHIBITOR; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; LEUKEMIA INHIBITORY FACTOR; MESSENGER RNA; METYRAPONE; POLYCLONAL ANTIBODY;

ADRENALECTOMY; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; CONTROLLED STUDY; CORTICOTROPIN RELEASE; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE SEPSIS; IMMUNE RESPONSE; IN VIVO STUDY; MOUSE; NONHUMAN; ORGAN CULTURE; PRIORITY JOURNAL; REVIEW; SEPTIC SHOCK; T LYMPHOCYTE; THYMUS ATROPHY;

ADRENAL CORTEX HORMONES; ADRENALECTOMY; ANIMALS; ATROPHY; ESCHERICHIA COLI; FEMALE; GROWTH INHIBITORS; INTERLEUKIN-6; LEUKEMIA INHIBITORY FACTOR; LIPOPOLYSACCHARIDES; LYMPHOKINES; MICE; MICE, INBRED BALB C; RNA, MESSENGER; THYMUS GLAND;

EID: 0036856473     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200211)32:11<3066::AID-IMMU3066>3.0.CO;2-J     Document Type: Review

References (22)

1. Stone, R., Search for sepsis drugs goes on despite past failures. Science 1994. 264: 365-367.
2. Billiau, A. and Vandekerckhove, F., Cytokines and their interactions with other inflammatory mediators in the pathogenesis of sepsis and septic shock. Eur. J. Clin. Invest. 1991. 21: 559-573.
3. Hotchkiss, R. S., Swanson, P. E., Freeman, B. D., Tinsley, K. W., Cobb, J. P., Matuschak, G. M., Buchman, T. G. and Karl, I. E., Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit. Care Med. 1999. 27: 1230-1251.
4. Wang, S. D., Huang, K. J., Lin, Y. S. and Lei, H. Y., Sepsis-induced apoptosis of the thymocytes in mice. J. Immunol. 1994. 152: 5014-5021.
5. Oberholzer, C., Oberholzer, A., Clare-Salzler, M. and Moldawar, L. L., Apoptosis in sepsis: a new target for therapeutic exploration. FASEB J. 2001. 15: 879-892.
6. Oberholzer, C., Oberholzer, A., Bahjat, F. R., Minter, R. M., Tannahill, C. L., Abouhamaze, A., LaFace, D., Hutchins, B., Clare-Salzlar, M. J. and Moldawer, L. L., Targeted adenovirus-induced expression of IL-10 decreases thymic apoptosis and improves survival in murine sepsis. Proc. Natl. Acad. Sci USA 2001. 98: 11503-11508.
7. Abraham, E., Anzueto, A., Gutierrez, G., Tessler, S., San Pedro, G., Wunderink, R., Dal Nogare, A., Nasraway, S., Berman, S., Cooney, R., Levy, H., Baughman, R., Rumbak, M., Light, R. B., Poole, L., Allred, R., Constant, J., Pennington, J. and Porter, S., Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group. Lancet 1998. 351: 929-933.
8. Fisher, C. J., Dhainaut, J. F., Opal, S. M., Pribble, J. P., Balk, R. A., Slotman, G. J., Iberti, T. J., Rackow, E. C., Shapiro, M. J. and Greenman, R. L., Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group. JAMA 1994. 271: 1836-1843.
9. Metcalf, D., Leukemia inhibitory factor - a puzzling polyfunctional regulator. Growth Factors 1992. 7: 169-173.
10. Patterson, P. H., The emerging neuropoietic cytokine family: first CDF/LIF, CNTF and IL-6; next ONC, MGF, GCSF? Curr. Opin. Neurobiol. 1992. 2: 94-97.
11. Gearing, D. P., Gough, N. M., King, J. A., Hilton, D. J., Nicola, N. A., Simpson, R. J., Nice, E. C., Kelso, A. and Metcalf, D., Molecular cloning and expression of cDNA encoding a murine myeloid leukaemia inhibitory factor (LIF). EMBO J. 1987. 6: 3995-4002.
12. Sempowski, G. D., Hale, L. P., Sundy, J. S., Massey, J. M., Koup, R. A., Douek, D. C., Patel, D. D. and Haynes, B. F., Leukemia inhibitory factor, oncostatin M, IL-6, and stem cell factor mRNA expression in human thymus increases with age and is associated with thymic atrophy. J. Immunol. 2000. 164: 2180-2187.
13. Shimon, I., Yan, X., Ray, D. W. and Melmed, S., Cytokine-dependent gp130 receptor subunit regulates human fetal pituitary adrenocorticotropin hormone and growth hormone secretion. J. Clin. Invest. 1997. 100: 357-363.
14. Wang, Z., Ren, S. G. and Melmed, S., Hypothalamic and pituitary leukemia inhibitory factor gene expression in vivo: a novel endotoxin-inducible neuro-endocrine interface. Endocrinology 1996. 137: 2947-2953.
15. Zhang, Y. H., Takahashi, K., Jiang, G. Z., Kawai, M., Fukada, M. and Yokochi, T., In vivo induction of apoptosis (programmed cell death) in mouse thymus by administration of lipopolysaccharide. Infect. Immun. 1993. 61: 5044-5048.
16. Metcalf, D., Nicola, N. A. and Gearing, D. P., Effects of injected leukemia inhibitory factor on hematopoietic and other tissues in mice. Blood 1990. 76: 50-56.
17. Plaut, M., Lymphocyte hormone receptors. Annu. Rev. Immunol. 1987. 5: 621-669.
18. Wyllie, A. H., Glucocorticoid-induced thymocyte apoptosis is associated with endogenous nuclease activation. Nature 1980. 284: 555-556.
19. Vacchio, M. S., Papadopoulos, V. and Ashwell, J. D., Steroid production in the thymus: implications for thymocyte selection. J. Exp. Med. 1994. 179: 1835-1846.
20. Ulich, T. R., Fann, M. J., Patterson, P. H., Williams, J. H., Samal, B., Del Castillo, J., Yin, S., Guo, K. and Remick, D. G., Intratracheal injection of LPS and cytokines. V. LPS induces expression of LIF and LIF inhibits acute inflammation. Am. J. Physiol. 1994. 267: L442-446.
21. Block, M. I., Berg, M., McNamara, M. J., Norton, J. A., Fraker, D. L. and Alexander, H. R., Passive immunization of mice against D factor blocks lethality and cytokine release during endotoxemia. J. Exp. Med. 1993. 178: 1085-1090.
22. Vacchio, M. S. and Ashwell, J. D., Thymus-derived glucocorticoids regulate antigen-specific positive selection. J. Exp. Med. 1997. 185: 2033-2038.